Go to homepage
Go to homepage
Share Your Story Donate

Press Releases

Stay Updated

Press Releases

RELEASE: All 12 Drug Manufacturers Agree To Participate In Second Round Of Medicare Negotiations

Patients For Affordable Drugs Welcomes Key Milestone While Holding Drug Companies Accountable For Ongoing Legal Attacks WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) announced Friday that all 12 manufacturers of the 15 drugs selected for the second round of the Medicare negotiation program voluntarily agreed to participate. While this is another critical step […]

Press Releases

Patients For Affordable Drugs Files Fourth Patient-Focused Amicus Brief, Defending The Historic Drug Pricing Law Against Attacks By Big Pharma

WASHINGTON, D.C. — Today, Patients For Affordable Drugs (P4AD) filed an amicus brief in the U.S. Court of Appeals for the Third Circuit, defending Medicare’s ability to negotiate lower drug prices against a lawsuit brought by pharmaceutical giant Novartis. The lawsuit is part of a broader industry-wide legal assault aimed at dismantling the 2022 prescription drug law’s historic […]

Press Releases

STATEMENT: Patients For Affordable Drugs Responds To Confirmation Of Robert F. Kennedy Jr. As HHS Secretary

WASHINGTON, D.C. — Following a narrow Senate vote, Robert F. Kennedy Jr., was confirmed today as Secretary of the Department of Health and Human Services (HHS). P4AD Executive Director, Merith Basey, released the following statement: “Secretary Kennedy has a critical opportunity – and responsibility – to build on existing measures to rein in Big Pharma’s price-gouging and lower drug […]

Press Releases

RELEASE: New Report Exposes PhRMA’s Misinformation Campaign To Undermine 2022 Prescription Drug Law

WASHINGTON, D.C. — A new report from Patients For Affordable Drugs reveals that the Pharmaceutical Research and Manufacturers of America (PhRMA) and its allies have spent heavily on advertisements – based on misleading and at times blatantly false claims – designed to undermine the 2022 prescription drug law – a law that is already lowering drug prices and […]

Press Releases

STATEMENT: Patients For Affordable Drugs Welcomes CMS Commitment to Medicare Negotiation, Emphasizes Need for Strong Price Cuts

WASHINGTON, D.C. — Patients For Affordable Drugs welcomes the Centers for Medicare & Medicaid Services (CMS) statement today reaffirming the continuation of Medicare drug price negotiation. P4AD Founder and President, David Mitchell, released the following statement in response: “We are very pleased to see the Medicare prescription drug program move forward under the Trump Administration. […]

Press Releases

RELEASE: Patients For Affordable Drugs Files Third Patient-Focused Amicus Brief, Defending The Historic Drug Pricing Law Against Attacks By Big Pharma

P4AD Pushes Back On Pharmaceutical Company Claims, Highlights The Drug Industry’s Decades-Long Prohibition On Medicare’s Ability To Negotiate Lower Drug Prices, And Amplifies The Experiences Of Patients WASHINGTON, D.C. — Patients For Affordable Drugs filed a 29-page amicus brief today in the U.S. Court of Appeals in the Second Circuit, defending the Medicare negotiation program […]

Press Releases

RELEASE: CMS Announces Next 15 Drugs Selected for Medicare Negotiation, Building On Historic Efforts To Lower Drug Prices

Patients For Affordable Drugs Celebrates Another Critical Step Forward in the Fight Against Skyrocketing Prescription Costs WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) has the 2024 milestone, when prices were successfully negotiated for the first 10 drugs under the 2022 prescription drug law, this expansion marks another major step toward ensuring […]